|
1
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
Burden of Disease Study 2010. LANCET. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barnes PJ: Cellular and molecular
mechanisms of chronic obstructive pulmonary disease. Clin Chest
Med. 35:71–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hillas G, Nikolakopoulou S, Hussain S and
Vassilakopoulos T: Antioxidants and mucolytics in COPD management:
When (if ever) and in whom? Curr Drug Targets. 14:225–234. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ottenheijm CA, Heunks LM and Dekhuijzen
RP: Diaphragm adaptations in patients with COPD. Respir Res.
9:122008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elkasrawy MN and Hamrick MW: Myostatin
(GDF-8) as a key factor linking muscle mass and bone structure. J
Musculoskelet Neuronal Interact. 10:56–63. 2010.PubMed/NCBI
|
|
6
|
Hayot M, Rodriguez J, Vernus B, Carnac G,
Jean E, Allen D, Goret L, Obert P, Candau R and Bonnieu A:
Myostatin up-regulation is associated with the skeletal muscle
response to hypoxic stimuli. Mol Cell Endocrinol. 332:38–47. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma K, Mallidis C, Bhasin S, Mahabadi V,
Artaza J, Gonzalez-Cadavid N, Arias J and Salehian B:
Glucocorticoid-induced skeletal muscle atrophy is associated with
upregulation of myostatin gene expression. Am J Physiol Endocrinol
Metab. 285:E363–E371. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vlahos R and Bozinovski S: Recent advances
in pre-clinical mouse models of COPD. Clin Sci (Lond). 126:253–265.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Jiang X, Zhang L, Wang L, Li Z and
Sun W: Simvastatin mitigates functional and structural impairment
of lung and right ventricle in a rat model of cigarette
smoke-induced COPD. Int J Clin Exp Pathol. 7:8553–8562.
2014.PubMed/NCBI
|
|
10
|
Wang Y, Jiang X, Zhang L, Wang L, Li Z and
Sun W: Simvastatin mitigates functional and structural impairment
of lung and right ventricle in a rat model of cigarette
smoke-induced COPD. Int J Clin Exp Pathol. 7:8553–8562.
2014.PubMed/NCBI
|
|
11
|
Jiang Y, Gao M, Wang W, Lang Y, Tong Z,
Wang K, Zhang H, Chen G, Liu M, Yao Y and Xiao X: Sinomenine
hydrochloride protects against polymicrobial sepsis via autophagy.
Int J Mol Sci. 16:2559–2573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Margaritopoulos GA, Vasarmidi E, Jacob J,
Wells AU and Antoniou KM: Smoking and interstitial lung diseases.
Eur Respir Rev. 24:428–435. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fricker M, Deane A and Hansbro PM: Animal
models of chronic obstructive pulmonary disease. Expert Opin Drug
Discov. 9:629–645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morris ZQ, Coz A and Starosta D: An
isolated reduction of the FEV3/FVC ratio is an indicator of mild
lung injury. Chest. 144:1117–1123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Andersen MP, Parham AR, Waldrep JC,
McKenzie WN and Dhand R: Alveolar fractal box dimension inversely
correlates with mean linear intercept in mice with elastase-induced
emphysema. Int J Chron Obstruct Pulmon Dis. 7:235–243. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wouters EF: Local and systemic
inflammation in chronic obstructive pulmonary disease. Proc Am
Thorac Soc. 2:pp. 26–33. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Plataki M, Tzortzaki E, Rytila P,
Demosthenes M, Koutsopoulos A and Siafakas NM: Apoptotic mechanisms
in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis.
1:161–171. 2006.PubMed/NCBI
|
|
18
|
Degens H, Swisher AK, Heijdra YF, Siu PM,
Dekhuijzen PN and Alway SE: Apoptosis and Id2 expression in
diaphragm and soleus muscle from the emphysematous hamster. Am J
Physiol Regul Integr Comp Physiol. 293:R135–R144. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barreiro E, Ferrer D, Sanchez F, Minguella
J, Marin-Corral J, Martinez-Llorens J, Lloreta J and Gea J:
Inflammatory cells and apoptosis in respiratory and limb muscles of
patients with COPD. J Appl Physiol (1985). 111:808–817. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tan Y, Sun L, Gao J and Ouyang X:
Apoptosis of diaphragmatic muscle cell in Chronic obstructive
pulmonary disease. J Clin Pulm Med,. 15:1580–1582. 2010.
|
|
21
|
Ji L, Sun L, Tan Y and Gu W: Adaptations
of diaphragmatic muscle fibres and apoptosis of diaphragmatic
muscle cell in rats with chronic obstructive pulmonary disease.
Acta U Med Nanjing(Natural Science). 32:194–198. 2012.
|
|
22
|
Levine S, Nguyen T, Kaiser LR, Rubinstein
NA, Maislin G, Gregory C, Rome LC, Dudley GA, Sieck GC and Shrager
JB: Human diaphragm remodeling associated with chronic obstructive
pulmonary disease: Clinical implications. Am J Respir Crit Care
Med. 168:706–713. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sauleda RJ: Clinical consequences of
muscle dysfunction in chronic obstructive pulmonary disease. Nutr
Hosp. 21(Suppl 3): 69–75. 2006.(In Spanish). PubMed/NCBI
|
|
24
|
McPherron AC, Lawler AM and Lee SJ:
Regulation of skeletal muscle mass in mice by a new TGF-beta
superfamily member. Nature. 387:83–90. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amthor H, Huang R, McKinnell I, Christ B,
Kambadur R, Sharma M and Patel K: The regulation and action of
myostatin as a negative regulator of muscle development during
avian embryogenesis. Dev Biol. 251:241–257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang W, Chen Y, Zhang Y, Wang X, Yang N
and Zhu D: Extracellular signal-regulated kinase 1/2
mitogen-activated protein kinase pathway is involved in
myostatin-regulated differentiation repression. Cancer Res.
66:1320–1326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sartori R, Gregorevic P and Sandri M:
TGFbeta and BMP signaling in skeletal muscle: potential
significance for muscle-related disease. Trends Endocrinol Metab.
25:464–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Testelmans D, Crul T, Maes K, Agten A,
Crombach M, Decramer M and Gayan-Ramirez G: Atrophy and hypertrophy
signalling in the diaphragm of patients with COPD. Eur Respir J.
35:549–556. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gea J, Agusti A and Roca J:
Pathophysiology of muscle dysfunction in COPD. J Appl Physiol
(1985). 114:1222–1234. 2013. View Article : Google Scholar : PubMed/NCBI
|
